PUBLISHER: The Business Research Company | PRODUCT CODE: 1942521
PUBLISHER: The Business Research Company | PRODUCT CODE: 1942521
Cardiac rhythm management (CRM) devices and equipment play a vital role in regulating heart rate and rhythm by administering electrical impulses or shocks to restore normal heart function. These devices are instrumental in managing arrhythmia-related conditions like cardiac arrests, heart failure, and various cardiac arrhythmias.
The primary products in the realm of cardiac rhythm management devices are pacemakers, defibrillators, and cardiac resynchronization therapy (CRT). Pacemakers, for instance, are compact devices implanted in the chest to regulate heartbeats, preventing slow heart rates. These devices serve purposes such as managing bradycardia, tachycardia, heart failure, and other related conditions. They are employed across different medical facilities, including hospitals, ambulatory surgical centers, and physician clinics.
Tariffs are influencing the cardiac rhythm management devices and equipment market by increasing costs of imported microelectronics, sensors, batteries, telemetry modules, and implantable device components. Hospitals and cardiac clinics in North America and Europe are most affected due to dependence on imported CRM technologies, while Asia-Pacific faces higher manufacturing and export-related costs. These tariffs are increasing device prices and impacting procurement cycles. However, they are also encouraging domestic device assembly, regional component sourcing, and long-term investment in localized CRM manufacturing ecosystems.
The cardiac rhythm management (crm) devices and equipment market research report is one of a series of new reports from The Business Research Company that provides cardiac rhythm management (crm) devices and equipment market statistics, including cardiac rhythm management (crm) devices and equipment industry global market size, regional shares, competitors with a cardiac rhythm management (crm) devices and equipment market share, detailed cardiac rhythm management (crm) devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the cardiac rhythm management (crm) devices and equipment industry. This cardiac rhythm management (crm) devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The cardiac rhythm management (crm) devices and equipment market size has grown rapidly in recent years. It will grow from $15.52 billion in 2025 to $17.07 billion in 2026 at a compound annual growth rate (CAGR) of 10.0%. The growth in the historic period can be attributed to rising incidence of cardiac arrhythmias, expansion of electrophysiology treatment centers, increasing use of pacemakers and defibrillators, improvements in device implantation techniques, growing awareness of sudden cardiac arrest management.
The cardiac rhythm management (crm) devices and equipment market size is expected to see strong growth in the next few years. It will grow to $21.22 billion in 2030 at a compound annual growth rate (CAGR) of 5.6%. The growth in the forecast period can be attributed to increasing demand for home-based cardiac monitoring, rising adoption of leadless pacemakers, expansion of heart failure management programs, growing investments in smart CRM platforms, continuous innovation in low-power device electronics. Major trends in the forecast period include increasing adoption of remote cardiac monitoring devices, rising use of miniaturized implantable crm devices, growing integration of ai-based arrhythmia detection, expansion of wireless and leadless technologies, enhanced focus on battery longevity and device safety.
The rise in the geriatric population is expected to drive the growth of the cardiac rhythm management (CRM) devices and equipment market in the coming years. The geriatric population includes individuals aged 65 and older. As this population increases, the prevalence of cardiovascular diseases also rises, resulting in greater demand for CRM devices. These devices assist in managing heart rhythm disorders, such as arrhythmias, and enhance the quality of life for older adults. For example, according to the Administration for Community Living, a U.S.-based government department, the older population is projected to reach 80.8 million by 2040 and 94.7 million by 2060. Consequently, the growing geriatric population is propelling the cardiac rhythm management (CRM) devices and equipment market.
The increasing incidence of cardiovascular diseases is also expected to boost the growth of the cardiac rhythm management (CRM) devices and equipment market. Cardiovascular diseases comprise a group of conditions affecting the heart and blood vessels, including coronary artery disease, heart attacks, strokes, hypertension, heart failure, and arrhythmias. The rise in these conditions is largely driven by unhealthy lifestyle factors, such as poor diet and lack of physical activity. CRM devices and equipment play a critical role in diagnosing, monitoring, and treating cardiovascular diseases, particularly those related to abnormal heart rhythms. For instance, in January 2024, according to the American Heart Association, a U.S.-based nonprofit organization, the age-adjusted death rate from cardiovascular disease rose to 233.3 per 100,000, up 4.0% from 224.4 per 100,000 in 2023. Therefore, the growing prevalence of cardiovascular diseases is fueling the CRM devices and equipment market.
Leading companies in the cardiac rhythm management (CRM) devices and equipment market are focusing on developing leadless and next-generation miniature pacemakers, such as dual-chamber leadless systems, to reduce complications related to leads, broaden patient eligibility, and improve long-term therapy durability. A dual-chamber/leadless pacemaker system is an implantable pacing device that provides both atrial and ventricular pacing without transvenous leads, using either two small self-contained implants that communicate with each other or a single miniaturized device with advanced sensing. This design lowers the risk of infection and lead failure while maintaining physiologic pacing. For example, in July 2023, Abbott, a U.S.-based medical device company, launched commercial implants of the AVEIR DR dual-chamber leadless pacemaker system following FDA approval earlier that year. This introduced the first leadless option for both atrial and ventricular pacing indications and enabled implant-to-implant communication for coordinated dual-chamber therapy.
Major companies operating in the cardiac rhythm management (crm) devices and equipment market are Abbott Laboratories, Medtronic plc, Biotronik SE & Co. KG, Cardiac Science Corporation, Schiller AG, Integer Holdings, Philips Healthcare, Rochling Medical, CCC Medical Devices, LivaNova plc, ZOLL Medical Corporation, Koninklijke Philips N.V., Applied Cardiac Systems, MicroPort Scientific Corporation, ReliantHeart Inc., Shree Pacetronix Ltd., Shaanxi Qinming Medical Instrument Co. Ltd., Boston Scientific Corporation, Progetti Srl, Medico S.p.A.
North America was the largest region in the global cardiac rhythm management (CRM) devices and equipment market in 2025. Western Europe was the second-largest region in the cardiac rhythm management (CRM) devices and equipment market. The regions covered in the cardiac rhythm management (crm) devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the cardiac rhythm management (crm) devices and equipment market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
The cardiac rhythm management (CRM) devices and equipment market consist of sales of Pacemakers, (implantable pacemakers, external pacemakers), defibrillators (implantable cardioverter defibrillators, external defibrillators), and cardiac resynchronization therapy (CRT-defibrillators, CRT-pacemakers) that are used for rhythm management. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cardiac Rhythm Management (CRM) Devices And Equipment Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses cardiac rhythm management (crm) devices and equipment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for cardiac rhythm management (crm) devices and equipment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cardiac rhythm management (crm) devices and equipment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.